Fred Grossman

Insider Reports History

Location
Houston, TX
Signature
/s/ David Snyder, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Fred Grossman:

Company Role Class Num Shares Value Price $ Report Date Ownership
Coya Therapeutics, Inc. Chief Medical Officer Common Stock, par value $0.0001 per share 2,710 $19,973 $7.37 11 Nov 2024 Direct
Coya Therapeutics, Inc. Chief Medical Officer Stock Option (right to buy) 140,562 09 Jan 2025 Direct

Insider Reports Filed by Fred Grossman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
COYA Coya Therapeutics, Inc. 09 Jan 2025 1 $0 4 Chief Medical Officer 13 Jan 2025, 08:00
COYA Coya Therapeutics, Inc. 11 Nov 2024 1 +$19,973 4 Chief Medical Officer 12 Nov 2024, 18:03
COYA Coya Therapeutics, Inc. 03 Jun 2024 1 $0 4 Chief Medical Officer 05 Jun 2024, 20:00
COYA Coya Therapeutics, Inc. 31 Jan 2024 2 $0 4 Chief Medical Officer 02 Feb 2024, 20:00
COYA Coya Therapeutics, Inc. 17 Jul 2023 1 $0 4 Chief Medical Officer 19 Jul 2023, 21:05
COYA Coya Therapeutics, Inc. 17 Jul 2023 0 $0 3 Chief Medical Officer 19 Jul 2023, 21:00